Compare · BE vs TMO
BE vs TMO
Side-by-side comparison of Bloom Energy Corporation (BE) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- BE operates in Energy, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $257.53B, about 3.7x BE ($69.60B).
- BE has been more active in the news (8 items in the past 4 weeks vs 6 for TMO).
- Both have 25 recent analyst ratings on file.
- Company
- Bloom Energy Corporation
- Thermo Fisher Scientific Inc
- Price
- $221.25-6.37%
- $690.13-0.92%
- Market cap
- $69.60B
- $257.53B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2018
- News (4w)
- 8
- 6
- Recent ratings
- 25
- 25
Bloom Energy Corporation
Bloom Energy Corporation designs, manufactures, and sells solid-oxide fuel cell systems for on-site power generation in the United States, Japan, China, India, and the Republic of Korea. The company offers Bloom Energy Server, a power generation platform that converts standard low-pressure natural gas, biogas, or hydrogen into electricity through an electrochemical process without combustion. It serves hospitals, healthcare companies, retailers, and data centers. The company was formerly known as Ion America Corp. and changed its name to Bloom Energy Corporation in September 2006. Bloom Energy Corporation was incorporated in 2001 and is headquartered in San Jose, California.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest BE
- Bloom Energy Supports Central Texas First Responders Ahead of Florida-Texas Matchup
- Bloom Energy Honors Gainesville Firefighters Who Prepare for the Moments That Matter
- Bloom Energy to Announce Third Quarter 2026 Financial Results on October 22, 2026
- The Unconventional Route to Fusion Power Just Hit a World First
- Director Warner Cynthia J was granted 83 shares, increasing direct ownership by 0.24% to 34,978 units (SEC Form 4)
- Director Immelt Jeffrey R was granted 81 shares, increasing direct ownership by 0.04% to 201,324 units (SEC Form 4)
- Chief Commercial Officer Joshi Aman sold $2,338,483 worth of shares (8,437 units at $277.17) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 147,092 units (SEC Form 4)
- Oracle Unveils Fusion Claw + Expands Agentic Applications: NYSE Content Update
- Powering Community Resilience, Bloom Energy Supports First Responders in State College during ESPN College Campus Tour
- Chief Commercial Officer Joshi Aman sold $972,054 worth of shares (3,601 units at $269.94) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 155,529 units (SEC Form 4) (tax liability)
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)